rs1270146

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005591.4(MRE11):​c.315-2379A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 152,042 control chromosomes in the GnomAD database, including 20,672 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 20672 hom., cov: 32)

Consequence

MRE11
NM_005591.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.06

Publications

7 publications found
Variant links:
Genes affected
MRE11 (HGNC:7230): (MRE11 homolog, double strand break repair nuclease) This gene encodes a nuclear protein involved in homologous recombination, telomere length maintenance, and DNA double-strand break repair. By itself, the protein has 3' to 5' exonuclease activity and endonuclease activity. The protein forms a complex with the RAD50 homolog; this complex is required for nonhomologous joining of DNA ends and possesses increased single-stranded DNA endonuclease and 3' to 5' exonuclease activities. In conjunction with a DNA ligase, this protein promotes the joining of noncomplementary ends in vitro using short homologies near the ends of the DNA fragments. This gene has a pseudogene on chromosome 3. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
MRE11 Gene-Disease associations (from GenCC):
  • ataxia-telangiectasia-like disorder 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • prostate cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.634 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005591.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MRE11
NM_005591.4
MANE Select
c.315-2379A>G
intron
N/ANP_005582.1
MRE11
NM_001440460.1
c.315-2379A>G
intron
N/ANP_001427389.1
MRE11
NM_001440461.1
c.315-2379A>G
intron
N/ANP_001427390.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MRE11
ENST00000323929.8
TSL:1 MANE Select
c.315-2379A>G
intron
N/AENSP00000325863.4
MRE11
ENST00000323977.7
TSL:1
c.315-2379A>G
intron
N/AENSP00000326094.3
MRE11
ENST00000540013.5
TSL:1
c.315-2379A>G
intron
N/AENSP00000440986.1

Frequencies

GnomAD3 genomes
AF:
0.514
AC:
78063
AN:
151924
Hom.:
20651
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.640
Gnomad AMI
AF:
0.227
Gnomad AMR
AF:
0.537
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.493
Gnomad SAS
AF:
0.603
Gnomad FIN
AF:
0.466
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.442
Gnomad OTH
AF:
0.517
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.514
AC:
78132
AN:
152042
Hom.:
20672
Cov.:
32
AF XY:
0.518
AC XY:
38494
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.640
AC:
26531
AN:
41452
American (AMR)
AF:
0.537
AC:
8209
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
1530
AN:
3468
East Asian (EAS)
AF:
0.491
AC:
2542
AN:
5172
South Asian (SAS)
AF:
0.604
AC:
2915
AN:
4826
European-Finnish (FIN)
AF:
0.466
AC:
4928
AN:
10574
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.442
AC:
30017
AN:
67948
Other (OTH)
AF:
0.511
AC:
1079
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1907
3813
5720
7626
9533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.469
Hom.:
9083
Bravo
AF:
0.521
Asia WGS
AF:
0.534
AC:
1855
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.092
DANN
Benign
0.19
PhyloP100
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1270146; hg19: chr11-94215306; API